Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies

NCT00763932 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Pompe Disease Infantile-Onset
Glycogen Storage Disease Type II

Interventions

BIOLOGICAL: Myozyme

Sponsor

Genzyme, a Sanofi Company